Schroeder U, Kreutz M R, Schroeder H, Sabel B A
Institute of Medical Psychology, Medical Faculty, Otto-von-Guericke University Magdeburg, Germany.
Pharmacol Biochem Behav. 1997 Feb;56(2):281-5. doi: 10.1016/s0091-3057(96)00291-2.
Two strains of mice (NMRI and C57B1/ 6) were treated with MPTP (within 8 h 4 x 30 mg/kg MPTP, IP) and motility was monitored 10 days later. An acute administration of amphetamine (2.5 mg/kg or 10.0 mg/kg) or apomorphine (0.5 mg/kg or 5.0 mg/kg) led to hypermotility and a dose-dependent increase of stereotyped behavior. Immunocytochemical investigations indicated a substantial loss of tyrosine-hydroxylase immunoreactivity in the basal ganglia which was accompanied by a 15% increase of 3H-spiroperidol binding to a striatal membrane preparation. No difference was found in biochemical and behavioral measures between both mice strains. Thus, MPTP-induced lesions in mice are probably followed by a denervation-like supersensitivity of the dopaminergic system, which might account for the finding that despite a severe degeneration of dopaminergic terminals amphetamine induces hypermotility.
将两种品系的小鼠(NMRI和C57B1/6)用MPTP处理(8小时内腹腔注射4次,每次30mg/kg MPTP),10天后监测其运动能力。急性给予苯丙胺(2.5mg/kg或10.0mg/kg)或阿扑吗啡(0.5mg/kg或5.0mg/kg)会导致运动亢进以及刻板行为呈剂量依赖性增加。免疫细胞化学研究表明,基底神经节中酪氨酸羟化酶免疫反应性大幅丧失,同时纹状体膜制剂上3H-螺哌啶醇结合增加了15%。在两种小鼠品系之间,生化和行为指标未发现差异。因此,MPTP诱导的小鼠损伤可能随后会出现多巴胺能系统的去神经样超敏反应,这可能解释了尽管多巴胺能终末严重退化,但苯丙胺仍能诱导运动亢进这一现象。